Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Open accessThe DOI matches its Crossref record; 621 of the 626 references it cites were found in a registry or an index.
Abstract
SUMMARY: Streptococcus pyogenes , also known as group A Streptococcus (GAS), causes mild human infections such as pharyngitis and impetigo and serious infections such as necrotizing fasciitis and streptococcal toxic shock syndrome. Furthermore, repeated GAS infections may trigger autoimmune diseases, including acute poststreptococcal glomerulonephritis, acute rheumatic fever, and rheumatic heart disease. Combined, these diseases account for over half a million deaths per year globally. Genomic and molecular analyses have now characterized a large number of GAS virulence determinants, many of which exhibit overlap and redundancy in the processes of adhesion and colonization, innate immune resistance, and the capacity to facilitate tissue barrier degradation and spread within the human host. This improved understanding of the contribution of individual virulence determinants to the disease process has led to the formulation of models of GAS disease progression, which may lead to better treatment and intervention strategies. While GAS remains sensitive to all penicillins and cephalosporins, rising resistance to other antibiotics used in disease treatment is an increasing worldwide concern. Several GAS vaccine formulations that elicit protective immunity in animal models have shown promise in nonhuman primate and early-stage human trials. The development of a safe and efficacious commercial human vaccine for the prophylaxis of GAS disease remains a high priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Upon detection of these Gram-positive pyogenic bacteria, neutrophil recruitment is critical to the resolution of infection (2).”
From Epidermal hepcidin is required for neutrophil response to bacterial infection (2019) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268 · cited 1×
“trophils at the site of infection to ensnare and kill bacteria (275).”
BackgroundPushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517 · cited 1×
“In GAS, tetracycline resistance is conferred by ribosome protection genes such as tet(M) or tet(O) (509).”
BackgroundInfectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
The global burden of group A streptococcal diseases
Carapetis, J. R., Steer, A. C., Mulholland, E. K., & Weber, M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70267-x · Cited by 2,998 · cited 8×
“A 2005 WHO study estimated that at least 663,000 cases of invasive GAS disease occur each year, resulting in 163,000 deaths (5).”
BackgroundInfluentialPlasminogen Activators, Tissue Degradation, and Cancer
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60028-7 · Cited by 2,535 · cited 1×
“Plasmin degradation of fibrinogen can also initiate the release of products that enhance blood vessel permeability and the accumulation of inflammatory cells (330, 331).”
BackgroundPathogenesis of Group A Streptococcal Infections
Cunningham, M. W. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.3.470 · Cited by 2,261 · cited 20×
“This disease burden includes over 2.4 million cases in patients aged 5 to 14 years, making RHD the most common cause of pediatric heart disease worldwide (73).”
BackgroundInfluentialPractice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602
Diversity of antimicrobial peptides and their mechanisms of action
Epand, R. M., & Vogel, H. J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00198-4 · Cited by 1,358 · cited 1×
“SpeB cleaves and inactivates human cathelicidin LL-37 (256), a small cationic antimicrobial peptide of the innate immune system produced by skin keratinocytes, mucosal epithelial cells, and neutrophils with bactericidal activity and electrostatic affinity for negatively charged bacterial surfaces (257).”
BackgroundStevens, D. L., Tanner, M. H., Winship, J., Swarts, R., Ries, K. M., Schlievert, P. M., & Kaplan, E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907063210101 · Cited by 1,216
Seppälä, H., Klaukka, T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K., & Huovinen, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370701 · Cited by 1,206
MSCRAMM-MEDIATED ADHERENCE OF MICROORGANISMS TO HOST TISSUES
Patti, J. M., Allen, B. L., McGavin, M. J., & Höök, M. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.003101 · Cited by 1,191 · cited 1×
“Cell surface adhesins that recognize ECM components have been termed MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) (148), which interact directly with ECM components such as fibronectin, collagen, and laminin.”
BackgroundShulman, S. T., Bisno, A. L., Clegg, H. W., Gerber, M. A., Kaplan, E. L., Lee, G., Martin, J. M., & Van Beneden, C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis629 · Cited by 1,092
Autophagy Defends Cells Against Invading Group A Streptococcus
Nakagawa, I., Amano, A., Mizushima, N., Yamamoto, A., Yamaguchi, H., Kamimoto, T., Nara, A., Funao, J., Nakata, M., Tsuda, K., et al. (2004) · Science · doi:10.1126/science.1103966 · Cited by 1,090 · cited 1×
“Once internalized, some GAS strains are susceptible to autophagy following escape from endosomes into the cytoplasm (161, 162).”
BackgroundComplete genome sequence of an M1 strain of Streptococcus pyogenes
Ferretti, J. J., McShan, W. M., Ajdic, D., Savic, D. J., Savic, G., Lyon, K., Primeaux, C., Sezate, S., Suvorov, A. N., Kenton, S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071559398 · Cited by 936 · cited 1×
“There are approximately 13 two-component regulatory systems (TCSs) and 100 putative standalone transcriptional regulators in the GAS genomes sequenced to date (34, 35, 39, 293).”
BackgroundMarijon, E., Mirabel, M., Celermajer, D. S., & Jouven, X. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61171-9 · Cited by 856
Bacteremia among Children Admitted to a Rural Hospital in Kenya
Berkley, J. A., Lowe, B. S., Mwangi, I., Williams, T., Bauni, E., Mwarumba, S., Ngetsa, C., Slack, M. P. E., Njenga, S., Hart, C. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa040275 · Cited by 851 · cited 1×
“0 per 100,000 [90]), and the Pacific Islands (9.”
BackgroundStreptococcal M protein: molecular design and biological behavior
Fischetti, V. A. (1989) · Clinical Microbiology Reviews · doi:10.1128/cmr.2.3.285 · Cited by 827
Invasive Group A Streptococcal Infections in Ontario, Canada
Davies, H. D., McGeer, A., Schwartz, B., Green, K., Cann, D., Simor, A. E., & Low, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350803 · Cited by 736
Invasive Group A Streptococcus Infections
Stevens, D. L. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.1.2 · Cited by 710
Guidelines for the Diagnosis of Rheumatic Fever: Jones Criteria, 1992 Update
Dajani, A. S. (1992) · JAMA · doi:10.1001/jama.1992.03490150121036 · Cited by 706
Rappuoli, R. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00119-3 · Cited by 704 · cited 1×
“Reverse vaccinology is the identification of vaccine targets through in silico analysis of the genome of the target pathogen, enabling the rapid discovery and identification of all possible antigens, putative virulence factors, and surface-associated proteins (585).”
BackgroundBuchanan, J. T., Simpson, A. J., Aziz, R. K., Liu, G. Y., Kristian, S. A., Kotb, M., Feramisco, J., & Nizet, V. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.039 · Cited by 682
Self-citationResurgence of Acute Rheumatic Fever in the Intermountain Area of the United States
Veasy, L. G., Wiedmeier, S. E., Orsmond, G. S., Ruttenberg, H. D., Boucek, M. M., Roth, S. J., Tait, V. F., Thompson, J. A., Daly, J. A., Kaplan, E. L., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702193160801 · Cited by 681 · cited 42×
“In a 2005 study, the highest rates of ARF were found in sub-Saharan Africa (5.7 cases per 1,000), in the Pacific Islander and indigenous minority populations of Australia and New Zealand (3.5 cases per 1,000), and south central Asia (United Nations regional classification) (2.2 cases per 1,000) (5).”
BackgroundInfluentialGerber, M. A., Baltimore, R. S., Eaton, C. B., Gewitz, M., Rowley, A. H., Shulman, S. T., & Taubert, K. A. (2009) · Circulation · doi:10.1161/circulationaha.109.191959 · Cited by 660 · cited 16×
“This disease burden includes over 2.4 million cases in patients aged 5 to 14 years, making RHD the most common cause of pediatric heart disease worldwide (73).”
BackgroundInfluentialStreptococcus Adherence and Colonization
Nobbs, A. H., Lamont, R. J., & Jenkinson, H. F. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00014-09 · Cited by 657 · cited 1×
“the bacterial surface by three known mechanisms: covalently to the cell wall peptidoglycan anchored via a C-terminal LPxTG (where x is any amino acid) motif, which is recognized by sortase A (116–118); covalently bound to the cell membrane through Nterminal modifications with lipid (lipoproteins) (113, 118); and throu…”
BackgroundPancholi, V, & Fischetti, V. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.2.415 · Cited by 625 · cited 9×
“GAPDH (also referred to as nephritis-associated plasminogen receptor [NAPlr]), SpeB, and streptokinase have been claimed to be possible nephritis-associated antigens (416, 418–420).”
BackgroundInfluentialDarenberg, J., Ihendyane, N., Sjolin, J., Aufwerber, E., Haidl, S., Follin, P., Andersson, J., Norrby-Teglund, A., & The Streptlg Study Group (2003) · Clinical Infectious Diseases · doi:10.1086/376630 · Cited by 573 · cited 1×
“An observational cohort study in Canada reported reduced mortality among patients treated with IVIG (460), and a European, multicenter, placebo-controlled trial designed to evaluate the efficacy and safety of IVIG showed a slight trend (not statistically significant) toward reduced mortality rates (461).”
BackgroundKaul, R., McGeer, A., Norrby‐Teglund, A., Kotb, M., Schwartz, B., O'Rourke, K., Talbot, J., Low, D. E., & The Canadian Streptococcal Study Group (1999) · Clinical Infectious Diseases · doi:10.1086/515199 · Cited by 544 · cited 3×
“While IVIG is sometimes considered for patients with invasive GAS who do not respond promptly to other therapeutic measures, current Infectious Diseases Society of America guidelines remind us that the levels of toxin-neutralizing antibodies vary considerably among different IVIG preparations and that additional studi…”
BackgroundSteer, A. C., Law, I., Matatolu, L., Beall, B. W., & Carapetis, J. R. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70178-1 · Cited by 537 · cited 1×
“A number of obstacles hinder the development of a GAS vaccine, including serotype diversity (528), antigenic variation (529), pronounced differences in the geographical distribution of serotypes (4), and, critically, the potential for GAS antigens to produce imGroup A Streptococcus Disease and Pathogenesis”
BackgroundCarapetis, J. R., McDonald, M., & Wilson, N. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66874-2 · Cited by 535
O'Loughlin, R. E., Roberson, A., Cieslak, P. R., Lynfield, R., Gershman, K., Craig, A., Albanese, B. A., Farley, M. M., Barrett, N. L., Spina, N. L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/521264 · Cited by 499
Beres, S. B., Sylva, G. L., Barbian, K. D., Lei, B., Hoff, J. S., Mammarella, N. D., Liu, M.-Y., Smoot, J. C., Porcella, S. F., Parkins, L. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152298499 · Cited by 499 · cited 1×
“There are approximately 13 two-component regulatory systems (TCSs) and 100 putative standalone transcriptional regulators in the GAS genomes sequenced to date (34, 35, 39, 293).”
BackgroundThe bacterial superantigen and superantigen‐like proteins
Fraser, J. D., & Proft, T. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00681.x · Cited by 495 · cited 1×
“These low-molecular-weight, secreted proteins have a highly conserved tertiary structure consisting of an N-terminal -barrel globular domain, a -grasp motif located within the C terminus, and 2 conserved amino acid motifs at the interface between the N- and C-terminal domains of the molecule (356).”
BackgroundStevens, D. L., Gibbons, A. E., Bergstrom, R., & Winn, V. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/158.1.23 · Cited by 473 · cited 2×
“Macrolides (erythromycin, azithromycin, and clarithromycin) are common alternative antibiotics used for patients who are allergic to penicillin, and the lincosamide antibiotic clindamycin is commonly used for the treatment of patients with life-threatening soft tissue infections, as it may reduce exotoxin production (…”
BackgroundMimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea
Kirvan, C. A., Swedo, S. E., Heuser, J. S., & Cunningham, M. W. (2003) · Nature Medicine · doi:10.1038/nm892 · Cited by 463 · cited 2×
“munity against host tissue that triggers autoimmune sequelae (400).”
BackgroundStructure and function of the plasminogen/plasmin system
Ploplis, V. A., & Castellino, F. J. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0842 · Cited by 460
Sumby, P., Whitney, A. R., Graviss, E. A., DeLeo, F. R., & Musser, J. M. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020005 · Cited by 459 · cited 11×
“Multiple neutrophil resistance factors are upregulated in covRS mutants, including the hyaluronic acid capsule, SIC, IdeS/Mac-1/ MspA, Sda1, SpeA, Ska, and C5a peptidase (294).”
BackgroundInfluentialHorstmann, R. D., Sievertsen, H. J., Knobloch, J., & Fischetti, V. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1657 · Cited by 451 · cited 1×
“protein (C4BP) (177–179), factor H (180), and factor H-like pro-”
BackgroundGroup A Streptococcal Infections and Acute Rheumatic Fever
Bisno, A. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109123251106 · Cited by 448
Dajani, A., Taubert, K., Ferrieri, P., Peter, G., Shulman, S., Committee on Rheumatic Fever, E., & American Heart Association (1995) · Pediatrics · doi:10.1542/peds.96.4.758 · Cited by 433 · cited 1×
“Most advisory groups recommend penicillin as the treatment of choice for GAS pharyngitis (434, 438), because of its narrow spectrum and because GAS has remained exquisitely susceptible to -lactam drugs (439).”
BackgroundGram-positive toxic shock syndromes
Lappin, E., & Ferguson, A. J. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70066-0 · Cited by 433 · cited 2×
“STSS can occur in conjunction with other GAS invasive diseases in response to superantigen production, resulting in a rapidly progressing illness characterized by high fever, rapid-onset hypotension, and accelerated multiorgan failure (291).”
BackgroundRodríguez-Ortega, M. J., Norais, N., Bensi, G., Liberatori, S., Capo, S., Mora, M., Scarselli, M., Doro, F., Ferrari, G., Garaguso, I., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1179 · Cited by 433 · cited 2×
“One such study used trypsin to “shave” surface-exposed proteins, which were subsequently identified by proteomics (588).”
BackgroundSmoot, J. C., Barbian, K. D., Van Gompel, J. J., Smoot, L. M., Chaussee, M. S., Sylva, G. L., Sturdevant, D. E., Ricklefs, S. M., Porcella, S. F., Parkins, L. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062526099 · Cited by 429 · cited 1×
“There are approximately 13 two-component regulatory systems (TCSs) and 100 putative standalone transcriptional regulators in the GAS genomes sequenced to date (34, 35, 39, 293).”
BackgroundCell wall sorting signals in surface proteins of gram‐positive bacteria.
Schneewind, O., Mihaylova‐Petkov, D., & Model, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06169.x · Cited by 426
DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection
Walker, M. J., Hollands, A., Sanderson-Smith, M. L., Cole, J. N., Kirk, J. K., Henningham, A., McArthur, J. D., Dinkla, K., Aziz, R. K., Kansal, R. G., et al. (2007) · Nature Medicine · doi:10.1038/nm1612 · Cited by 426 · cited 4×
“Spontaneous and unidirectional mutations within covRS affect the expression of numerous virulence factors important for impeding the host innate immune response (294, 314) and the initiation and progression of GAS invasive disease (20, 277, 294).”
BackgroundInfluentialSelf-citationThe cell biology of the plasminogen system
Plow, E. F., Herren, T., Redlitz, A., Miles, L. A., & Hoover‐Plow, J. L. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615163 · Cited by 420 · cited 1×
“Additionally, plasmin activation of prometalloproteases results in the degradation of the collagen structural components of the ECM, further facilitating widespread tissue destruction (326).”
BackgroundEpidemiology of Severe Streptococcus pyogenes Disease in Europe
Lamagni, T. L., Darenberg, J., Luca-Harari, B., Siljander, T., Efstratiou, A., Henriques-Normark, B., Vuopio-Varkila, J., Bouvet, A., Creti, R., Ekelund, K., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00422-08 · Cited by 410 · cited 8×
“The result is a massive cytokine response by T cells (lymphotoxin- , IL-2, and IFN- ) and antigen-presenting cells (TNF- , IL-1 , and IL-6), which causes widespread tissue damage, disseminated intravascular thrombosis, and organ dysfunction (7, 81, 291, 292).”
BackgroundInfluentialPlasminogen is a critical host pathogenicity factor for group A streptococcal infection
Sun, H., Ringdahl, U., Homeister, J. W., Fay, W. P., Engleberg, N. C., Yang, A. Y., Rozek, L. S., Wang, X., Sjöbring, U., & Ginsburg, D. (2004) · Science · doi:10.1126/science.1101245 · Cited by 408 · cited 5×
“Epidemiological studies suggest that GAS strains associated with invasive disease bind plasminogen more avidly than those associated with benign infection (319), and the ability to accumulate cell surface plasmin is a prerequisite for systemic infection by multiple GAS serotypes (255, 258, 325).”
BackgroundInfluentialFischetti, V. A., Pancholi, V., & Schneewind, O. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02072.x · Cited by 407 · cited 1×
“The M protein is a major surface protein and virulence factor of GAS, which is anchored to the cell wall peptidoglycan through an LPxTG motif (117, 131).”
BackgroundKotb, M., Norrby-Teglund, A., McGeer, A., El-Sherbini, H., Dorak, M. T., Khurshid, A., Green, K., Peeples, J., Wade, J., Thomson, G., et al. (2002) · Nature Medicine · doi:10.1038/nm1202-800 · Cited by 398 · cited 3×
“Serum levels of proinflammatory mediators are strongly linked to the severity of infection (282, 289, 354).”
BackgroundMechanism of membrane damage by streptolysin-O
Bhakdi, S., Tranum-Jensen, J., & Sziegoleit, A. (1985) · Infection and Immunity · doi:10.1128/iai.47.1.52-60.1985 · Cited by 394 · cited 2×
“SLO promotes resistance to phagocytic killing by disrupting the integrity of host cell membranes (220), inducing rapid caspase-dependent apoptosis in neutrophils, macrophages (221), and epithelial cells (222).”
BackgroundUnconstrained bacterial promiscuity: the Tn916–Tn1545 family of conjugative transposons
Clewell, D. B., Flannagan, S. E., Jaworski, D. D., & Clewell, D. B. (1995) · Trends in Microbiology · doi:10.1016/s0966-842x(00)88930-1 · Cited by 391
Graham, M. R., Smoot, L. M., Migliaccio, C. A. L., Virtaneva, K., Sturdevant, D. E., Porcella, S. F., Federle, M. J., Adams, G. J., Scott, J. R., & Musser, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202353699 · Cited by 390 · cited 2×
“Both ex vivo and in vivo studies demonstrate that controlled expression of bacterial genes in response to changes in the host environment facilitates the transition from superficial to invasive infection (20, 294, 295).”
BackgroundMora, M., Bensi, G., Capo, S., Falugi, F., Zingaretti, C., Manetti, A. G. O., Maggi, T., Taddei, A. R., Grandi, G., & Telford, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507808102 · Cited by 387 · cited 1×
“Discovered in 2005, GAS pili, or fimbriae, appear as long, flexible rods protruding up to 3 m from the cell surface (119).”
BackgroundMolecular insight into invasive group A streptococcal disease
Cole, J. N., Barnett, T. C., Nizet, V., & Walker, M. J. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2648 · Cited by 377 · cited 13×
“, phospholipase), tissue-damaging enzymes released by activated host neutrophils, and a proinflammatory cytokine cascade arising from uncontrolled T-cell responses to superantigens (20, 61, 85, 282, 286).”
BackgroundInfluentialSelf-citationHerwald, H., Cramer, H., Mörgelin, M., Russell, W., Sollenberg, U., Norrby-Teglund, A., Flodgaard, H., Lindbom, L., & Björck, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00057-1 · Cited by 375 · cited 2×
“Subsequent neutrophil degranulation leads to the release of heparin binding protein and other inflammatory mediators (352).”
BackgroundJohnson, D. R., Stevens, D. L., & Kaplan, E. L. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.2.374 · Cited by 366 · cited 1×
“Examples include the association of emm types 1, 3, and 49 with invasive disease and emm types 2, 4, 6, 12, and 44/61 with superficial disease (46, 58, 59).”
BackgroundPathogenic bacteria attach to human fibronectin through a tandem β-zipper
Schwarz-Linek, U., Werner, J. M., Pickford, A. R., Gurusiddappa, S., Kim, J. H., Pilka, E. S., Briggs, J. A. G., Gough, T. S., Höök, M., Campbell, I. D., et al. (2003) · Nature · doi:10.1038/nature01589 · Cited by 361
Sumby, P., Porcella, S. F., Madrigal, A. G., Barbian, K. D., Virtaneva, K., Ricklefs, S. M., Sturdevant, D. E., Graham, M. R., Vuopio‐Varkila, J., Hoe, N. P., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/432514 · Cited by 360 · cited 10×
“Multiple neutrophil resistance factors are upregulated in covRS mutants, including the hyaluronic acid capsule, SIC, IdeS/Mac-1/ MspA, Sda1, SpeA, Ska, and C5a peptidase (294).”
BackgroundInfluentialClancy, J., Petitpas, J., Dib‐Hajj, F., Yuan, W., Cronan, M., Kamath, A. V., Bergeron, J., & Retsema, J. A. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.01521.x · Cited by 358 · cited 1×
“In target drug efflux, mefA (macrolide efflux pump) genes encode an efflux pump of 14- and 15-carbonring macrolides (494), conferring resistance to erythromycin only.”
BackgroundEpidemiology of Invasive Group A Streptococcus Disease in the United States, 1995–1999
O’Brien, K. L., Beall, B., Barrett, N. L., Cieslak, P. R., Reingold, A., Farley, M. M., Danila, R., Zell, E. R., Facklam, R., Schwartz, B., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/341409 · Cited by 357
Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci.
Wessels, M. R., Moses, A. E., Goldberg, J. B., & DiCesare, T. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8317 · Cited by 351 · cited 1×
“Nonencapsulated GAS mutants are susceptible to phagocytic clearance in vitro and have dramatically reduced virulence in murine models of invasive GAS disease (202, 205).”
BackgroundResistance to Erythromycin in Group A Streptococci
Seppälä, H., Nissinen, A., Järvinen, H., Huovinen, S., Henriksson, T., Herva, E., Holm, S. E., Jahkola, M., Katila, M.-L., Klaukka, T., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260503 · Cited by 350
Mechanisms of Antibiotic Resistance in Staphylococcus Aureus
Pantosti, A., Sanchini, A., & Monaco, M. (2007) · Future Microbiology · doi:10.2217/17460913.2.3.323 · Cited by 348
On the Kinetics of the Reaction between Human Antiplasmin and Plasmin
WIMAN, B., & COLLEN, D. (1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb12200.x · Cited by 342 · cited 1×
“The major circulating inhibitor of plasmin is 2-antiplasmin; however, plasmin bound to cell surface receptors, or surfaces such as fibrin, is partially protected from inactivation by 2-antiplasmin (327).”
BackgroundSumby, P., Barbian, K. D., Gardner, D. J., Whitney, A. R., Welty, D. M., Long, R. D., Bailey, J. R., Parnell, M. J., Hoe, N. P., Adams, G. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406641102 · Cited by 340 · cited 2×
“Serotype M1T1 GAS secretes the bacteriophage-encoded DNase Sda1, also known as SdaD2 (276), which degrades NETs and protects serotype M1T1 strains from neutrophil-mediated killing (277, 278).”
BackgroundStreptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface.
Phillips, G. N., Flicker, P. F., Cohen, C., Manjula, B. N., & Fischetti, V. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4689 · Cited by 329 · cited 1×
“The M protein exists as a dimer consisting of two polypeptide chains complexed into an -helical coiled-coil configuration that extends beyond the GAS surface as hairlike projections (132).”
BackgroundHanski, E., & Caparon, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6172 · Cited by 328 · cited 6×
“The fibronectin binding repeats of PrtF1/SfbI bind the Fc region of human IgG in a nonimmune fashion, which prevents 272 cmr.asm.org Clinical Microbiology Reviews phagocytosis by macrophages and antibody-dependent cell-mediated toxicity (240, 241).”
BackgroundInfluentialGroup A Streptococcal Diseases and Their Global Burden
Ralph, A. P., & Carapetis, J. R. (2012) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2012_280 · Cited by 327 · cited 1×
“While scarlet fever was a significant cause of childhood morbidity and mortality in the 19th and early 20th centuries, global rates have steadily declined over the last 150 to 200 years such that it was considered a relatively rare disease until recently (67, 68).”
BackgroundKreikemeyer, B., McIver, K. S., & Podbielski, A. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00098-2 · Cited by 324 · cited 1×
“Additionally, the expression of GAS adhesins is highly regulated in response to environmental factors (163).”
BackgroundZIMBELMAN, J., PALMER, A., & TODD, J. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199912000-00014 · Cited by 322
Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s
Cleary, P. P., Schlievert, P. M., Handley, J. P., Kim, M. H., Hauser, A. R., Kaplan, E. L., & Wlazlo, A. (1992) · The Lancet · doi:10.1016/0140-6736(92)90339-5 · Cited by 321 · cited 11×
“Multiple neutrophil resistance factors are upregulated in covRS mutants, including the hyaluronic acid capsule, SIC, IdeS/Mac-1/ MspA, Sda1, SpeA, Ska, and C5a peptidase (294).”
BackgroundInfluentialSafety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers
McNeil, S. A., Halperin, S. A., Langley, J. M., Smith, B., Warren, A., Sharratt, G. P., Baxendale, D. M., Reddish, M. A., Hu, M. C., Stroop, S. D., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/444458 · Cited by 305 · cited 1×
“Two N-terminal M protein vaccine preparations have reached human clinical trials to date: a hexavalent preparation (444, 539, 540) and a 26-valent preparation (541, 542).”
BackgroundCytolysin-Mediated Translocation (CMT)
Madden, J. C., Ruiz, N., & Caparon, M. (2001) · Cell · doi:10.1016/s0092-8674(01)00198-2 · Cited by 300 · cited 1×
“Nicotinamide dehydrogenase (NAD-glycohydrolase) is coexpressed with SLO and transported into the cytoplasm of target cells through SLO-induced pores to deplete intracellular energy stores and augment host cell injury (224).”
BackgroundClinical and Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe
Luca-Harari, B., Darenberg, J., Neal, S., Siljander, T., Strakova, L., Tanna, A., Creti, R., Ekelund, K., Koliou, M., Tassios, P. T., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02155-08 · Cited by 300
The Current State of Poststreptococcal Glomerulonephritis
Rodriguez-Iturbe, B., & Musser, J. M. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010092 · Cited by 296 · cited 1×
“However, for each of these proteins, there are counterarguments expressing doubts over their involvement in APSGN pathogenesis (421).”
BackgroundOkada, N., Liszewski, M. K., Atkinson, J. P., & Caparon, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2489 · Cited by 290 · cited 1×
“Additionally, the M6 protein binds directly to ligands present on host cells, such as the keratinocyte membrane cofactor CD46 (145), and the M1 protein can bind to surface-expressed glycosaminoglycans, including dermatan sulfate, heparan sulfate, and heparin (146).”
BackgroundIncorporation of D-Alanine into Lipoteichoic Acid and Wall Teichoic Acid in Bacillus subtilis
Perego, M., Glaser, P., Minutello, A., Strauch, M. A., Leopold, K., & Fischer, W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.26.15598 · Cited by 286 · cited 1×
“dinated by the dltABCD operon (263), increases the net positive”
BackgroundNakagawa, I., Kurokawa, K., Yamashita, A., Nakata, M., Tomiyasu, Y., Okahashi, N., Kawabata, S., Yamazaki, K., Shiba, T., Yasunaga, T., et al. (2003) · Genome Research · doi:10.1101/gr.1096703 · Cited by 277
Multiple adhesins of streptococci
Hasty, D. L., Ofek, I., Courtney, H. S., & Doyle, R. J. (1992) · Infection and Immunity · doi:10.1128/iai.60.6.2147-2152.1992 · Cited by 276 · cited 2×
“Initial bacterial attachment is hypothesized to be a two-stage process involving weak and/or long-range interactions followed by more specific, high-affinity binding (114).”
BackgroundLevin, J. C., & Wessels, M. R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01057.x · Cited by 274 · cited 5×
“pyogenes (IdeS), and the DNase Sda1 (294, 308).”
BackgroundInfluentialInvasive Group A Streptococcal Disease: Epidemiology, Pathogenesis and Management
Steer, A. C., Lamagni, T., Curtis, N., & Carapetis, J. R. (2012) · Drugs · doi:10.2165/11634180-000000000-00000 · Cited by 273
Federle, M. J., McIver, K. S., & Scott, J. R. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.12.3649-3657.1999 · Cited by 271 · cited 2×
“The ihk-irr two-component regulatory system is comprised of the isp-adjacent response regulator (irr) and the isp-adjacent histidine kinase (ihk) (296).”
BackgroundÅkesson, P., Sjöholm, A. G., & Björck, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.1081 · Cited by 268 · cited 1×
“Streptococcal inhibitor of complement-mediated lysis (SIC) is a secreted 31-kDa virulence factor uniquely expressed by serotype M1 and M57 GAS strains (209) that binds and inhibits the complement C5b67 complex to prevent formation of the membrane attack complex (209, 210), which is generally ineffective against the th…”
BackgroundThe role of the streptococcus in the pathogenesis of rheumatic fever
Catanzaro, F. J., Stetson, C. A., Morris, A. J., Chamovitz, R., Rammelkamp, C. H., Stolzer, B. L., & Perry, W. D. (1954) · The American Journal of Medicine · doi:10.1016/0002-9343(54)90219-3 · Cited by 261 · cited 41×
“In a 2005 study, the highest rates of ARF were found in sub-Saharan Africa (5.7 cases per 1,000), in the Pacific Islander and indigenous minority populations of Australia and New Zealand (3.5 cases per 1,000), and south central Asia (United Nations regional classification) (2.2 cases per 1,000) (5).”
BackgroundInfluentialThe Role of -Lactamase-Producing Bacteria in the Persistence of Streptococcal Tonsillar Infection
Brook, I. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.5.601 · Cited by 260
Kristian, S. A., Datta, V., Weidenmaier, C., Kansal, R., Fedtke, I., Peschel, A., Gallo, R. L., & Nizet, V. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.19.6719-6725.2005 · Cited by 258 · cited 1×
“lysozyme, and neutrophil-mediated killing (264).”
Self-citationDale, J. B., Penfound, T. A., Chiang, E. Y., & Walton, W. J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.005 · Cited by 258
A Novel Erythromycin Resistance Methylase Gene ( ermTR ) in Streptococcus pyogenes
Seppälä, H., Skurnik, M., Soini, H., Roberts, M. C., & Huovinen, P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.257 · Cited by 258 · cited 1×
“This results in a conformational change in the ribosome, leading to reduced binding of macrolide-lincosamide-streptogramin Btype antibiotics (493).”
BackgroundStreptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation
Manetti, A. G. O., Zingaretti, C., Falugi, F., Capo, S., Bombaci, M., Bagnoli, F., Gambellini, G., Bensi, G., Mora, M., Edwards, A. M., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05704.x · Cited by 248 · cited 1×
“Additionally, pili contribute to microcolony formation on human cells and the formation of biofilm (129).”
BackgroundSriskandan, S., & Altmann, D. (2008) · The Journal of Pathology · doi:10.1002/path.2274 · Cited by 248
Ellen, R. P., & Gibbons, R. J. (1972) · Infection and Immunity · doi:10.1128/iai.5.5.826-830.1972 · Cited by 248
Wessels, M. R. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1009126 · Cited by 246
Crystal Structure of the Catalytic Domain of Human Plasmin Complexed with Streptokinase
Wang, X., Lin, X., Loy, J. A., Tang, J., & Zhang, X. C. (1998) · Science · doi:10.1126/science.281.5383.1662 · Cited by 244 · cited 1×
“Ska is a single-chain, 414-amino-acid protein composed of three distinct domains (333).”
BackgroundImmunogenicity of a 26-Valent Group A Streptococcal Vaccine
Hu, M. C., Walls, M. A., Stroop, S. D., Reddish, M. A., Beall, B., & Dale, J. B. (2002) · Infection and Immunity · doi:10.1128/iai.70.4.2171-2177.2002 · Cited by 241 · cited 1×
“Two N-terminal M protein vaccine preparations have reached human clinical trials to date: a hexavalent preparation (444, 539, 540) and a 26-valent preparation (541, 542).”
BackgroundPAM, a novel plasminogen-binding protein from Streptococcus pyogenes.
Berge, A., & Sjöbring, U. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74408-1 · Cited by 235 · cited 17×
“Once bound to the M protein, plasminogen can be readily activated to plasmin by both host activators (tPA and uPA) and Ska (337).”
BackgroundInfluentialErythromycin-Resistant Group A Streptococci in Schoolchildren in Pittsburgh
Martin, J. M., Green, M., Barbadora, K. A., & Wald, E. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013169 · Cited by 234 · cited 1×
“A rapid increase in the percentage of macrolide-resistant strains may also be due to the clonal expansion of a single resistant strain (442, 498, 504).”
BackgroundHeath, A., DiRita, V. J., Barg, N. L., & Engleberg, N. C. (1999) · Infection and Immunity · doi:10.1128/iai.67.10.5298-5305.1999 · Cited by 234 · cited 1×
“The impairment of local inflammatory cells by SLS may promote the dissemination of GAS throughout the host (233).”
BackgroundBessen, D., Jones, K. F., & Fischetti, V. A. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.269 · Cited by 233
Green, N. M., Zhang, S., Porcella, S. F., Nagiec, M. J., Barbian, K. D., Beres, S. B., LeFebvre, R. B., & Musser, J. M. (2005) · The Journal of Infectious Diseases · doi:10.1086/430618 · Cited by 232
Thern, A., Stenberg, L., Dahlbäck, B., & Lindahl, G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.375 · Cited by 230
Surface Proteins of Gram-Positive Bacteria and How They Get There
Scott, J. R., & Barnett, T. C. (2006) · Annual Review of Microbiology · doi:10.1146/annurev.micro.60.080805.142256 · Cited by 230 · cited 1×
“the bacterial surface by three known mechanisms: covalently to the cell wall peptidoglycan anchored via a C-terminal LPxTG (where x is any amino acid) motif, which is recognized by sortase A (116–118); covalently bound to the cell membrane through Nterminal modifications with lipid (lipoproteins) (113, 118); and throu…”
BackgroundSelf-citationDeAngelis, P. L., Papaconstantinou, J., & Weigel, P. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36494-4 · Cited by 229 · cited 2×
“The third gene in the operon, hasC, is not essential for GAS capsule biosynthesis (196, 197).”
BackgroundBerge, A., & Björck, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9862 · Cited by 222 · cited 1×
“Cleavage of the M protein from the GAS cell surface by SpeB results in the presence of soluble M protein fragments at the site of infection (351).”
BackgroundSwedo, S. E., Leonard, H. L., & Rapoport, J. L. (2004) · Pediatrics · doi:10.1542/peds.113.4.907 · Cited by 221 · cited 1×
“A definitive association between PANDAS and antecedent GAS infection is still quite debatable (402, 403).”
BackgroundPili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin
Abbot, E. L., Smith, W. D., Siou, G. P. S., Chiriboga, C., Smith, R. J., Wilson, J. A., Hirst, B. H., & Kehoe, M. A. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00918.x · Cited by 220 · cited 1×
“Pili mediate the attachment of M1 GAS (strain SF370) to human tonsillar epithelium and to primary human keratinocytes (128).”
BackgroundGenetic Locus for Streptolysin S Production by Group A Streptococcus
Nizet, V., Beall, B., Bast, D. J., Datta, V., Kilburn, L., Low, D. E., & De Azavedo, J. C. S. (2000) · Infection and Immunity · doi:10.1128/iai.68.7.4245-4254.2000 · Cited by 216 · cited 2×
“SLS is encoded by a conserved nine-gene operon, comprised of the genes sagA to sagI (SLS-associated gene), which is responsible for the characteristic zone of beta-hemolysis surrounding GAS colonies on the surface of blood agar medium (229, 230).”
BackgroundSelf-citationBeres, S. B., Richter, E. W., Nagiec, M. J., Sumby, P., Porcella, S. F., DeLeo, F. R., & Musser, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510279103 · Cited by 214
Colman, G., Tanna, A., Efstratiou, A., & Gaworzewska, E. T. (1993) · Journal of Medical Microbiology · doi:10.1099/00222615-39-3-165 · Cited by 214
Dahesh, S., Hensler, M. E., Van Sorge, N. M., Gertz, R. E., Schrag, S., Nizet, V., & Beall, B. W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00461-08 · Cited by 211 · cited 1×
“icillin nonsusceptibility have been demonstrated in group B Streptococcus (483).”
BackgroundSelf-citationPérez-Trallero, E., Fernández-Mazarrasa, C., Garcı́a-Rey, C., Bouza, E., Aguilar, L., Garcı́a-de-Lomas, J., Baquero, F., & The Spanish Surveillance Group for Respiratory Pathogens (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3334-3340.2001 · Cited by 210
Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease
Guilherme, L., Kalil, J., & Cunningham, M. (2006) · Autoimmunity · doi:10.1080/08916930500484674 · Cited by 209 · cited 16×
“This disease burden includes over 2.4 million cases in patients aged 5 to 14 years, making RHD the most common cause of pediatric heart disease worldwide (73).”
BackgroundInfluentialKurlan, R., Johnson, D., Kaplan, E. L., & and the Tourette Syndrome Study Group (2008) · Pediatrics · doi:10.1542/peds.2007-2657 · Cited by 208 · cited 2×
“As such, the pathogenesis of PANDAS remains unknown, but it has been hypothesized that GAS infection results in antineuronal antibodies (79).”
BackgroundStreptococcus and rheumatic fever
Cunningham, M. W. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835461d3 · Cited by 206 · cited 1×
“Cunningham proposed that antibody mimicries trigger oligoclonal T-cell expansion, followed by their extravasation into the valve through valvular endothelial cells (395).”
BackgroundEffect of SpeB and EndoS from Streptococcus pyogenes on Human Immunoglobulins
Collin, M., & Olsén, A. (2001) · Infection and Immunity · doi:10.1128/iai.69.11.7187-7189.2001 · Cited by 203 · cited 13×
“The IgG-degrading enzyme of S. pyogenes (IdeS), also known as Mac-1, Sib35, and MspA, inhibits phagocytosis, neutrophil activation, and the release of reactive oxygen species by binding Fc receptor CD16 (Fc RIIIB) on the surface of neutrophils (242, 243).”
BackgroundInfluentialEffect of antibiotic therapy on the clinical course of streptococcal pharyngitis
Randolph, M. F., Gerber, M. A., DeMeo, K. K., & Wright, L. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80228-6 · Cited by 201 · cited 1×
“Antibiotics shorten the clinical course of GAS pharyngitis (435); however, most signs and symptoms spontaneously resolve within 3 to 4 days, even without antibiotic treatment (436).”
BackgroundCaparon, M. G., & Scott, J. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8677 · Cited by 201
Edwards, R. J., Taylor, G. W., Ferguson, M., Murray, S., Rendell, N., Wrigley, A., Bai, Z., Boyle, J., Finney, S. J., Jones, A., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/432485 · Cited by 201
PANDAS: current status and directions for research
Snider, L. A., & Swedo, S. E. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001542 · Cited by 200
Roles of integrins and fibronectin in the entry of Streptococcus pyogenes into cells via protein F1
Ozeri, V., Rosenshine, I., Mosher, D. F., Fässler, R., & Hanski, E. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01097.x · Cited by 199
Engleberg, N. C., Heath, A., Miller, A., Rivera, C., & DiRita, V. J. (2001) · The Journal of Infectious Diseases · doi:10.1086/319291 · Cited by 198 · cited 1×
“Consequently, GAS isolates with mutations in either covR or covS are more resistant to phagocytosis and killing by human neutrophils (294) and are hypervirulent in mouse models of systemic GAS infection (277, 315).”
BackgroundCloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor
Lottenberg, R., Broder, C. C., Boyle, M. D., Kain, S. J., Schroeder, B. L., & Curtiss, R. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.16.5204-5210.1992 · Cited by 197
Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet
Rodríguez-Iturbe, B., & Batsford, S. (2007) · Kidney International · doi:10.1038/sj.ki.5002169 · Cited by 197 · cited 1×
“Such a mechanism has been proposed (422, 423).”
BackgroundTalkington, D. F., Schwartz, B., Black, C. M., Todd, J. K., Elliott, J., Breiman, R. F., & Facklam, R. R. (1993) · Infection and Immunity · doi:10.1128/iai.61.8.3369-3374.1993 · Cited by 195
Group A Streptococci Among School-Aged Children: Clinical Characteristics and the Carrier State
Martin, J. M., Green, M., Barbadora, K. A., & Wald, E. R. (2004) · Pediatrics · doi:10.1542/peds.2004-0133 · Cited by 193 · cited 1×
“Carriers are unlikely to spread GAS to their close contacts and are at very low, if any, risk for developing suppurative or nonsuppurative complications (451, 452).”
BackgroundSIC, a Secreted Protein of Streptococcus pyogenesThat Inactivates Antibacterial Peptides
Frick, I.-M., Åkesson, P., Rasmussen, M., Schmidtchen, A., & Björck, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301995200 · Cited by 193
Batzloff, M. R., Hayman, W. A., Davies, M. R., Zeng, M., Pruksakorn, S., Brandt, E. R., & Good, M. F. (2003) · The Journal of Infectious Diseases · doi:10.1086/374800 · Cited by 192
Hoy, W. E., White, A. V., Dowling, A., Sharma, S. K., Bloomfield, H., Tipiloura, B. T., Swanson, C. E., Mathews, J. D., & McCredie, D. A. (2012) · Kidney International · doi:10.1038/ki.2011.478 · Cited by 188
Streptococcus pyogenes Serotype M1 Encodes Multiple Pathways for Entry into Human Epithelial Cells
Cue, D., Dombek, P. E., Lam, H., & Cleary, P. P. (1998) · Infection and Immunity · doi:10.1128/iai.66.10.4593-4601.1998 · Cited by 188 · cited 2×
“M proteins (M1, M3, and M6) may promote bacterial colonization by binding directly to components of the ECM, such as fibronectin (140, 141).”
BackgroundBessen, D., & Fischetti, V. A. (1988) · Infection and Immunity · doi:10.1128/iai.56.10.2666-2672.1988 · Cited by 186
Acute rheumatic fever – Authors' reply
Carapetis, J. R., McDonald, M., & Wilson, N. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67560-5 · Cited by 184
The IL-8 Protease SpyCEP/ScpC of Group A Streptococcus Promotes Resistance to Neutrophil Killing
Zinkernagel, A. S., Timmer, A. M., Pence, M. A., Locke, J. B., Buchanan, J. T., Turner, C. E., Mishalian, I., Sriskandan, S., Hanski, E., & Nizet, V. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.07.002 · Cited by 184 · cited 1×
“killing (267) and enhances virulence a murine model of systemic”
BackgroundSelf-citationFaé, K. C., da Silva, D. D., Oshiro, S. E., Tanaka, A. C., Pomerantzeff, P. M. A., Douay, C., Charron, D., Toubert, A., Cunningham, M. W., Kalil, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5662 · Cited by 183 · cited 16×
“This disease burden includes over 2.4 million cases in patients aged 5 to 14 years, making RHD the most common cause of pediatric heart disease worldwide (73).”
BackgroundInfluentialStreptolysin O Promotes Group A Streptococcus Immune Evasion by Accelerated Macrophage Apoptosis
Timmer, A. M., Timmer, J. C., Pence, M. A., Hsu, L.-C., Ghochani, M., Frey, T. G., Karin, M., Salvesen, G. S., & Nizet, V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804632200 · Cited by 183 · cited 4×
“The central importance of SLO in GAS disease pathogenesis is supported by findings that SLO mutants are attenuated for virulence in subcutaneous, intravenous, and intraperitoneal mouse models of invasive GAS disease (221, 227, 228).”
BackgroundInfluentialSelf-citationUpdated model of group A Streptococcus M proteins based on a comprehensive worldwide study
McMillan, D. J., Drèze, P. A., Vu, T., Bessen, D. E., Guglielmini, J., Steer, A. C., Carapetis, J. R., Van Melderen, L., Sriprakash, K. S., & Smeesters, P. R. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12134 · Cited by 183 · cited 1×
“A number of obstacles hinder the development of a GAS vaccine, including serotype diversity (528), antigenic variation (529), pronounced differences in the geographical distribution of serotypes (4), and, critically, the potential for GAS antigens to produce imGroup A Streptococcus Disease and Pathogenesis”
BackgroundSelf-citationRise and Persistence of Global M1T1 Clone of Streptococcus pyogenes
Aziz, R. K., & Kotb, M. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1410.071660 · Cited by 183 · cited 11×
“Multiple neutrophil resistance factors are upregulated in covRS mutants, including the hyaluronic acid capsule, SIC, IdeS/Mac-1/ MspA, Sda1, SpeA, Ska, and C5a peptidase (294).”
BackgroundInfluentialTerao, Y., Kawabata, S., Kunitomo, E., Murakami, J., Nakagawa, I., & Hamada, S. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02579.x · Cited by 183 · cited 7×
“Mga activity has been linked to carbohydrate metabolism (143, 303, 305), and variation in the phosphorylation of Mga in response to differences in sugar availability alters Mga function (306).”
BackgroundInfluentialMalhotra-Kumar, S., Lammens, C., Piessens, J., & Goossens, H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4798-4800.2005 · Cited by 183
Lei, B., DeLeo, F. R., Hoe, N. P., Graham, M. R., Mackie, S. M., Cole, R. L., Liu, M., Hill, H. R., Low, D. E., Federle, M. J., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1298 · Cited by 182 · cited 1×
“pyogenes (IdeS), also known as Mac-1, Sib35, and MspA, inhibits phagocytosis, neutrophil activation, and the release of reactive oxygen species by binding Fc receptor CD16 (Fc RIIIB) on the surface of neutrophils (242, 243).”
BackgroundStreptococcal skin infection and rheumatic heart disease
Parks, T., Smeesters, P. R., & Steer, A. C. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283511d27 · Cited by 181 · cited 1×
“Due to the high rates of impetigo and low rates of GAS pharyngitis in the indigenous Australian population, it has been proposed that ARF can also occur as a complication of impetigo, although this has not been confirmed (74).”
BackgroundThe Long-Term Course of Poststreptococcal Glomerulonephritis
BALDWIN, D. S., GLUCK, M. C., SCHACHT, R. G., & GALLO, G. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-342 · Cited by 180
Genetic Correlates of Throat and Skin Isolates of Group A Streptococci
Bessen, D. E., Sotir, C. M., Readdy, T. L., & Hollingshead, S. K. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.4.896 · Cited by 180 · cited 1×
“The chromosomal arrangement of emm and emm-like genes is a genetic marker for tissue site preference, and these arrangements, referred to as emm patterns, consist of five major groups, patterns A to E (165).”
BackgroundType-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein
Beachey, E. H., Seyer, J. M., Dale, J. B., Simpson, W. A., & Kang, A. H. (1981) · Nature · doi:10.1038/292457a0 · Cited by 179
Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci
Dale, J. B., Washburn, R. G., Marques, M. B., & Wessels, M. R. (1996) · Infection and Immunity · doi:10.1128/iai.64.5.1495-1501.1996 · Cited by 179 · cited 2×
“The GAS capsule blocks antibody access to surface epitopes (200), inhibits complement deposition (188), promotes resistance to opsonophagocytosis (188, 189), enhances survival within neutrophil extracellular traps (NETs) (201), and is necessary for full virulence in mouse (202–205) and nonhuman primate (206) models of…”
BackgroundGOLDSTEIN, I., HALPERN, B., & ROBERT, L. (1967) · Nature · doi:10.1038/213044a0 · Cited by 177 · cited 1×
“However, immunological crossreactivity between anti-GAC antibodies and host heart valve proteins (563) and cytoskeletal proteins, such as actin, keratin, myosin, and vimentin (392), raises important potential safety concerns regarding the use of GAC as a GAS vaccine constituent.”
BackgroundBanks, D. J., Porcella, S. F., Barbian, K. D., Beres, S. B., Philips, L. E., Voyich, J. M., DeLeo, F. R., Martin, J. M., Somerville, G. A., & Musser, J. M. (2004) · The Journal of Infectious Diseases · doi:10.1086/422697 · Cited by 177
Lukomski, S., Nakashima, K., Abdi, I., Cipriano, V. J., Ireland, R. M., Reid, S. D., Adams, G. G., & Musser, J. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6542-6553.2000 · Cited by 177
Streptococcal C5a peptidase is a highly specific endopeptidase
Cleary, P. P., Prahbu, U., Dale, J. B., Wexler, D. E., & Handley, J. (1992) · Infection and Immunity · doi:10.1128/iai.60.12.5219-5223.1992 · Cited by 176 · cited 12×
“Multiple neutrophil resistance factors are upregulated in covRS mutants, including the hyaluronic acid capsule, SIC, IdeS/Mac-1/ MspA, Sda1, SpeA, Ska, and C5a peptidase (294).”
BackgroundInfluentialKendall, F. E., Heidelberger, M., & Dawson, M. H. (1937) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)74517-1 · Cited by 174 · cited 1×
“ular-mass polymer of glucuronic -1,3-N-acetylglucosamine (195) and is structurally identical to the hyaluronic acid expressed on human cell surfaces and connective tissue, allowing GAS to subvert the host immune response through molecular mimicry (6).”
BackgroundFAILURE OF PENICILLIN TO ERADICATE GROUP A STREPTOCOCCI DURING AN OUTBREAK OF PHARYNGITIS
Gastanaduy, A., Huwe, B., Kaplan, E., Mckay, C., & Wannamaker, L. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91832-2 · Cited by 174 · cited 1×
“Despite universal sensitivity to penicillin, GAS infections may fail to respond to penicillin therapy, leading to persistent throat carriage and recurrent infections (473, 474).”
BackgroundRevisiting the pathogenesis of rheumatic fever and carditis
Tandon, R., Sharma, M., Chandrashekhar, Y., Kotb, M., Yacoub, M. H., & Narula, J. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.197 · Cited by 174 · cited 1×
“Although it is possible that not all aspects of ARF/RHD disease pathogenesis could be attributable to crossreactivity (399), it is believed that the anticollagen antibodies and recurring stimulation of T cells at the valve may result in tissue scarring.”
BackgroundIkebe, T., Ato, M., Matsumura, T., Hasegawa, H., Sata, T., Kobayashi, K., & Watanabe, H. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000832 · Cited by 173 · cited 1×
“Less frequently, mutations in the standalone regulator ropB (alternatively known as rgg) have also been identified in invasive GAS isolates (316, 317).”
BackgroundGuilherme, L., & Kalil, J. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9332-6 · Cited by 173 · cited 17×
“This disease burden includes over 2.4 million cases in patients aged 5 to 14 years, making RHD the most common cause of pediatric heart disease worldwide (73).”
BackgroundInfluentialKotloff, K. L., Corretti, M., Palmer, K., Campbell, J. D., Reddish, M. A., Hu, M. C., Wasserman, S. S., & Dale, J. B. (2004) · JAMA · doi:10.1001/jama.292.6.709 · Cited by 173
Cunningham, M. W., McCormack, J. M., Fenderson, P. G., Ho, M. K., Beachey, E. H., & Dale, J. B. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2677 · Cited by 173 · cited 2×
“In the M5 and M6 proteins, the epitope responsible for eliciting this response was found to be the amino acid sequence QKSKQ (390).”
BackgroundGarcía-Rey, C., Aguilar, L., Baquero, F., Casal, J., & Dal-Ré, R. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.1.159-164.2002 · Cited by 173
Carlsson, F., Berggård, K., Stålhammar‐Carlemalm, M., & Lindahl, G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030543 · Cited by 171 · cited 1×
“M and Mlp typically bind the Fc region of IgA, while Mrp binds the Fc region of IgG, preventing complement activation on the GAS cell surface (238, 239).”
BackgroundMolecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics
Beres, S. B., Carroll, R. K., Shea, P. R., Sitkiewicz, I., Martinez-Gutierrez, J. C., Low, D. E., McGeer, A., Willey, B. M., Green, K., Tyrrell, G. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911295107 · Cited by 170 · cited 1×
“demonstrated that successive waves of M3 infections in Canada were attributed to different subclones that arose primarily by horizontal phage transfer (56).”
BackgroundTerao, Y., Yamaguchi, M., Hamada, S., & Kawabata, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513408200 · Cited by 170 · cited 1×
“trophil chemotaxis and H2O2 production (274).”
Hayman, W. (1997) · International Immunology · doi:10.1093/intimm/9.11.1723 · Cited by 166
Group A streptococcal infections in children
Steer, A. C., Danchin, M. H., & Carapetis, J. R. (2007) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2007.01051.x · Cited by 165
Rheumatic Fever Following Streptococcal Vaccination: Report of Three Cases
Massell, B. F. (1969) · JAMA · doi:10.1001/jama.207.6.1115 · Cited by 165
Ji, Y., Carlson, B., Kondagunta, A., & Cleary, P. P. (1997) · Infection and Immunity · doi:10.1128/iai.65.6.2080-2087.1997 · Cited by 164 · cited 4×
“The proteolytic degradation of chemotactic substances such as IL-8 and C5a by S. pyogenes cell envelope protease (SpyCEP) and ScpA, respectively, impairs neutrophil recruitment, impeding phagocytosis at the site of infection and promoting GAS survival in vivo.”
BackgroundInfluentialStreptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea
Kirvan, C. A., Swedo, S. E., Kurahara, D., & Cunningham, M. W. (2006) · Autoimmunity · doi:10.1080/08916930500484757 · Cited by 164
Jeng, A., Sakota, V., Li, Z., Datta, V., Beall, B., & Nizet, V. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.4.1208-1217.2003 · Cited by 164
Self-citationBessen, D. E., Carapetis, J. R., Beall, B., Katz, R., Hibble, M., Currie, B. J., Collingridge, T., Izzo, M. W., Scaramuzzino, D. A., & Sriprakash, K. S. (2000) · The Journal of Infectious Diseases · doi:10.1086/315842 · Cited by 163 · cited 1×
“Risk factors for skin infection include crowding, poor living conditions, and high rates of scabies infection, which may explain the relative prevalence of emm pattern D strains in indigenous populations, while crowding in places such as schools is the major risk factor for pharyngeal infection with GAS strains belong…”
BackgroundSelf-citationVoyich, J. M., Sturdevant, D. E., Braughton, K. R., Kobayashi, S. D., Lei, B., Virtaneva, K., Dorward, D. W., Musser, J. M., & DeLeo, F. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337370100 · Cited by 162
Bessen, D. E., & Kalia, A. (2002) · Infection and Immunity · doi:10.1128/iai.70.3.1159-1167.2002 · Cited by 161 · cited 2×
“The pilus biosynthesis and sortase genes are grouped together as a pathogenicity island located in the FCT region of the GAS genome, which encodes fibronectin binding proteins, collagen binding proteins, and T antigens (pilus subunit genes) (125).”
BackgroundKurlan, R., & Kaplan, E. L. (2004) · Pediatrics · doi:10.1542/peds.113.4.883 · Cited by 161 · cited 1×
“A definitive association between PANDAS and antecedent GAS infection is still quite debatable (402, 403).”
BackgroundPathogenesis of Group A Streptococcal Infections and Their Sequelae
Cunningham, M. W. (2008) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-73960-1_3 · Cited by 161 · cited 1×
“Acute rheumatic fever (ARF) is a systemic disorder that can follow untreated GAS pharyngeal infection (71).”
BackgroundLeckman, J. F., King, R. A., Gilbert, D. L., Coffey, B. J., Singer, H. S., Dure IV, L. S., Grantz, H., Katsovich, L., Lin, H., & Lombroso, P. J. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.10.011 · Cited by 160 · cited 1×
“tion to the exacerbation of disease symptoms (78, 79).”
BackgroundSuperantigen antagonist protects against lethal shock and defines a new domain for T-cell activation
Arad, G., Levy, R., Hillman, D., & Kaempfer, R. (2000) · Nature Medicine · doi:10.1038/74672 · Cited by 158 · cited 1×
“Finally, SpeA, SpeI, SSA, SmeZ, SpeH, and SpeO contain a conserved CD28 binding site that recognizes the CD28 molecule on T cells (363, 364).”
BackgroundQuinn, R. W. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.6.928 · Cited by 158 · cited 1×
“While scarlet fever was a significant cause of childhood morbidity and mortality in the 19th and early 20th centuries, global rates have steadily declined over the last 150 to 200 years such that it was considered a relatively rare disease until recently (67, 68).”
BackgroundDiagnosis and treatment of streptococcal pharyngitis
Fink, H. W. (1985) · JAMA · doi:10.1001/jama.254.7.907 · Cited by 157
Antibiotic Effects on Bacterial Viability, Toxin Production, and Host Response
Stevens, D. L., Bryant, A. E., & Hackett, S. P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.supplement_2.s154 · Cited by 157 · cited 1×
“Macrolides (erythromycin, azithromycin, and clarithromycin) are common alternative antibiotics used for patients who are allergic to penicillin, and the lincosamide antibiotic clindamycin is commonly used for the treatment of patients with life-threatening soft tissue infections, as it may reduce exotoxin production (…”
BackgroundBrandt, E. R., Sriprakash, K. S., Hobb, R. I., Hayman, W. A., Zeng, W., Batzloff, M. R., Jackson, D. C., & Good, M. F. (2000) · Nature Medicine · doi:10.1038/74719 · Cited by 156
Self-citationCourtney, H. S., Li, Y., Dale, J. B., & Hasty, D. L. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.3937-3946.1994 · Cited by 156
Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes.
Chen, C. C., & Cleary, P. P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39748-0 · Cited by 155 · cited 1×
“isolates and is located within the mga regulon (269).”
BackgroundThe Prevention of Invasive Group A Streptococcal Infections Workshop Participants (2002) · Clinical Infectious Diseases · doi:10.1086/342692 · Cited by 155
The Mga virulence regulon: infection where the grass is greener
Hondorp, E. R., & McIver, K. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.06006.x · Cited by 154 · cited 1×
“Loci that form discrete phylogenetic lineages, which can then be associated with tissue-specific emm patterns, include the transcriptional regulators mga (a global regulator of numerous virulence factors) (173), rofA and nra (mutually exclusive transcriptional regulators of the genes in the FCT region) (167), and ska…”
BackgroundStreptolysin S-like virulence factors: the continuing sagA
Molloy, E. M., Cotter, P. D., Hill, C., Mitchell, D. A., & Ross, R. P. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2624 · Cited by 154 · cited 1×
“SLO is a 69-kDa cholesterol-dependent and oxygen-labile cytolysin that contributes to beta-hemolysis under the surface of blood agar medium (219).”
BackgroundBates, C. S., Montañez, G. E., Woods, C. R., Vincent, R. M., & Eichenbaum, Z. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1042-1055.2003 · Cited by 154
Trigger for group A streptococcal M1T1 invasive disease
Cole, J. N., Mcarthur, J. D., Mckay, F. C., Sanderson-Smith, M. L., Cork, A. J., Ranson, M., Rohde, M., Itzek, A., Sun, H., Ginsburg, D., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5804fje · Cited by 154 · cited 8×
“Ska expression is negatively regulated by covRS, and SpeB readily degrades and inactivates streptokinase (255, 294).”
BackgroundInfluentialSelf-citationStreptococcal M Protein: A Multipotent and Powerful Inducer of Inflammation
Påhlman, L. I., Mörgelin, M., Eckert, J., Johansson, L., Russell, W., Riesbeck, K., Soehnlein, O., Lindbom, L., Norrby-Teglund, A., Schumann, R. R., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1221 · Cited by 153
Severe Streptococcal Infections in Historical Perspective
Katz, A. R., & Morens, D. M. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.1.298 · Cited by 153
Xu, D., Trajkovic, V., Hunter, D., Leung, B. P., Schulz, K., Gracie, J. A., McInnes, I. B., & Liew, F. Y. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200011)30:11<3147::aid-immu3147>3.0.co;2-j · Cited by 153
Johnsson, E., Berggård, K., Kotarsky, H., Hellwage, J., Zipfel, P. F., Sjöbring, U., & Lindahl, G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4894 · Cited by 153 · cited 3×
“Complement-inhibitory proteins, including C4b binding protein (C4BP) (177–179), factor H (180), and factor H-like protein 1 (FHL-1) (181), are bound by the M protein to thwart complement deposition and efficient opsonophagocytosis.”
BackgroundSierig, G., Cywes, C., Wessels, M. R., & Ashbaugh, C. D. (2003) · Infection and Immunity · doi:10.1128/iai.71.1.446-455.2003 · Cited by 151 · cited 1×
“The expression of both SLO and SLS enhanced GAS virulence in a mouse model of bacterial sepsis (235).”
BackgroundCarlsson, F., Sandin, C., & Lindahl, G. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04527.x · Cited by 151
Macrolide-Resistant Streptococcus pyogenes in the United States, 2002-2003
Richter, S. S., Heilmann, K. P., Beekmann, S. E., Miller, N. J., Miller, A. L., Rice, C., Doern, C. D., Reid, S. D., & Doern, G. V. (2005) · Clinical Infectious Diseases · doi:10.1086/432473 · Cited by 149
Moses, A. E., Wessels, M. R., Zalcman, K., Albertí, S., Natanson-Yaron, S., Menes, T., & Hanski, E. (1997) · Infection and Immunity · doi:10.1128/iai.65.1.64-71.1997 · Cited by 148 · cited 1×
“Nonencapsulated GAS mutants are susceptible to phagocytic clearance in vitro and have dramatically reduced virulence in murine models of invasive GAS disease (202, 205).”
BackgroundMechanism of tetracycline resistance by ribosomal protection protein Tet(O)
Li, W., Atkinson, G. C., Thakor, N. S., Allas, Ü., Lu, C.-C., Chan, K.-Y., Tenson, T., Schulten, K., Wilson, K. S., Hauryliuk, V., et al. (2013) · Nature Communications · doi:10.1038/ncomms2470 · Cited by 147 · cited 1×
“These proteins share homology with elongation factors EF-G and EF-Tu and possess GTPase activity that is important for the displacement of tetracycline from the ribosome (510, 511).”
Neeman, R., Keller, N., Barzilai, A., Korenman, Z., & Sela, S. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12452-7 · Cited by 147
White, A. V., Hoy, W. E., & McCredie, D. A. (2001) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2001.tb143394.x · Cited by 146
Murphy, T. K., Kurlan, R., & Leckman, J. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0043 · Cited by 146 · cited 1×
“The literature on whether GAS infection has a role in PANDAS and related neurological disorders has recently been critically reviewed (401).”
BackgroundGetting under the Skin: The Immunopathogenesis of Streptococcus pyogenes Deep Tissue Infections
Johansson, L., Thulin, P., Low, D. E., & Norrby‐Teglund, A. (2010) · Clinical Infectious Diseases · doi:10.1086/653116 · Cited by 145 · cited 3×
“, phospholipase), tissue-damaging enzymes released by activated host neutrophils, and a proinflammatory cytokine cascade arising from uncontrolled T-cell responses to superantigens (20, 61, 85, 282, 286).”
BackgroundDalton, T. L., & Scott, J. R. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.12.3928-3937.2004 · Cited by 145 · cited 2×
“The control of virulence regulatory system (covRS), also known as the capsule synthesis regulon (csrRS) (296, 307, 308), encodes a membrane-bound sensor kinase (CovS) and a DNA binding response regulator (CovR) (309).”
BackgroundFc-receptor and M-protein genes of group A streptococci are products of gene duplication.
Heath, D. G., & Cleary, P. P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4741 · Cited by 144 · cited 1×
“The GAS Ig binding M proteins, M-related proteins (Mrp), and M-like proteins (Mlp or Enn) are classified into the M protein family (237).”
BackgroundSevere Group A Streptococcal Soft-Tissue Infections in Ontario: 1992–1996
Sharkawy, A., Low, D. E., Saginur, R., Gregson, D. B., Schwartz, B., Jessamine, P. G., Green, K., McGeer, A., & Ontario Group A Streptococcal Study Group (2002) · Clinical Infectious Diseases · doi:10.1086/338466 · Cited by 144
Research works printed but not linked: 3
- Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470–511. 10.1128/CMR.13.3.470-511.2000 [DOI] [PMC free article] [PubMed] [Google Scholar] · doi:10.1128/cmr.13.3.470-511.2000 · Paper page
- WHO. 2005. The current evidence for the burden of group A streptococcal diseases. WHO report. WHO, Geneva, Switzerland [Google Scholar]
- American Academy of Pediatrics. 2012. Group A streptococcal infections, p 668–680 In Pickering LK, Baker CJ, Kimberlin DW, Long SS. (ed), Red book: 2012 report of the Committee on Infectious Diseases. American Academy of Pediatrics, Elk Grove Village, IL [Google Scholar]
Cited by
The wound microbiota: microbial mechanisms of impaired wound healing and infection
Uberoi, A., McCready-Vangi, A., & Grice, E. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01035-z · Cited by 864
“Interestingly, most adhesin proteins are not present universally across all GAS strains and it is thought that expression and/or regulation of adhesins plays a role in determining tissue tropism of GAS bacteria 79 .”
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Karki, R., & Kanneganti, T.-D. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.06.001 · Cited by 438
Pathogenesis, epidemiology and control of Group A Streptococcus infection
Brouwer, S., Rivera-Hernandez, T., Curren, B. F., Harbison-Price, N., De Oliveira, D. M. P., Jespersen, M. G., Davies, M. R., & Walker, M. J. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00865-7 · Cited by 374
Self-citationEmerging and Neglected Infectious Diseases: Insights, Advances, and Challenges
Nii-Trebi, N. I. (2017) · BioMed Research International · doi:10.1155/2017/5245021 · Cited by 356
“By understanding the dynamics of disease and the means of contracting it, methods of fighting, preventing, and controlling are developed [2, 5, 6].”
Lawrence, J. G., Carapetis, J. R., Griffiths, K., Edwards, K., & Condon, J. R. (2013) · Circulation · doi:10.1161/circulationaha.113.001477 · Cited by 282
Metadata
- Authors
- Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V.
- Affiliations
- The University of Queensland (AU)
- University of Wollongong (AU)
- QIMR Berghofer Medical Research Institute (AU)
- School of Biological Sciences and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia
- University of California San Diego (US)
- Corresponding author
- Walker, Mark J.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2014-04
- Volume
- 27
- Issue
- 2
- Pages
- 264-301
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC3993104
- OpenAlex
- W2145736155
- Cited by
- 908
- References
- 626
- Citations by year
- 2026: 74 · 2025: 85 · 2024: 96 · 2023: 81 · 2022: 82 · 2021: 87 · 2020: 91 · 2019: 76 · 2018: 57 · 2017: 59 · 2016: 55 · 2015: 50 · 2014: 12
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Online (University of Wollongong) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI077780)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052728)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Keywords
- Streptococcus pyogenes, virulence factors, pathogenesis, pharyngitis, impetigo, necrotizing fasciitis, toxic shock syndrome, post-streptococcal glomerulonephritis, rheumatic fever, rheumatic heart disease, innate immune evasion, tissue degradation, antibiotic resistance, streptococcal vaccine, disease progression model
- MeSH terms
- Animals, Anti-Bacterial Agents, Disease Models, Animal, Humans, Streptococcal Infections, Streptococcus pyogenes, Virulence, Streptococcal Vaccines, Drug Resistance, Bacterial, Virulence Factors, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.